Xiaole Zuo

No ORCID on file · 1 paper in corpus

other 2026

CEBPD may function as a molecular indicator of fibrotic severity and negative regulator of fibrosis in uterine leiomyoma through regulating EMT progression

Frontiers in pharmacology ·doi:10.3389/fphar.2026.1839523

OBJECTIVE: To investigate the expression pattern, diagnostic value, and molecular mechanism of CCAAT/enhancer-binding protein delta (CEBPD) in uterine leiomyoma (ULM)-associated fibrosis, and to identify novel diagnostic biomarkers and ther…